Narratives, uncertainty and subjectivity in the context of regenerative medicine

María José  Miranda Suárez

doi:10.54502/msuceva.v3n2a4

Autores/as

María José Miranda Suárez University of Oviedo: Oviedo, Asturias, Spain

DOI:

https://doi.org/10.54502/msuceva.v3n2a4

Palabras clave:

Bioeconomy, donors, public health, regenerative medicine

Resumen

The emergence of bio-economies and debates about what biomaterials can be used in stem cell research are shaping subjectivities and identities in biomedicine today. Narratives of neoliberal nation-states often emphasise the idea that responsibility for health problems lies directly with the citizenry, while social safety nets are increasingly reduced. This creates a sense of security for citizens by endorsing certain therapeutic promises that semiotically disconnect the material conditions of uncertainty in which these cell therapy technologies are developed. In this respect, the study of the discursive practices associated with these technologies introduces a new performative understanding of the concept of health in regenerative medicine

Descargas

Los datos de descargas todavía no están disponibles.

Métricas

Cargando métricas ...

Biografía del autor/a

María José Miranda Suárez, University of Oviedo: Oviedo, Asturias, Spain

A graduate in Philosophy (University of Oviedo / Uviéu, 2004), she completed her studies with the Benito Feijoo End of Degree Award. Thanks to the funding provided by the CSIC Introduction to Research Scholarships, the Ramón Areces Foundation Predoctoral Scholarship and the CSIC I3P Predoctoral Scholarship and Contract.

She was able to complete his Inter-University Doctoral Degree in Logic and Philosophy of Science under the supervision of Eulalia Pérez Sedeño at the Institute of Philosophy of the CSIC, graduating cum laude from the University of Santiago de Compostela in 2013. During this time, she has also specialised in gender and techno-scientific communication with the European Mobility Scholarship of the PRIME Network of Excellence (2007), developed at the Department of Science, Technology, Health and Policy Studies at the University of Twente. (Netherlands). At the same time, he continued his studies with a Masters in Journalism and Science Communication at UNED in 2009. He also collaborated with the Department of Sociology of the Federal University of Pernambuco in his research on the pathologisation of suffering in contemporary times in 2013. He currently teaches subjects in Aesthetics in the Philosophy degree and several subjects in the Interuniversity Master in Science, Technology and Innovation Studies at the University of Oviedo / Uviéu, the University of Salamanca and the Universitat Politècnica de València. He also collaborates in the research project Praxeology of Scientific Culture. Concepts and dimensions of the University of Oviedo / Uviéu (FFI2017-82217-C2-1-P).

Citas

Haddad C. Embodied values: post-pharmaceutical health and the accumulation of surplus vitality in regenerative stem cell medicine. Sociologias 2019; 21:48–79. https://doi.org/10.1590/15174522-02105002 DOI: https://doi.org/10.1590/15174522-02105002

Organisation for Economic Co-operation and Development -OECD. Scoping document. The bioeconomy to 2030: Designing a policy agenda. Paris,France: 2006. https://web-archive.oecd.org/2012-06-15/144237-36972476.pdf.

Commission of the European Communities. Life Sciences and Biotechnology – a strategy for Europe: Communication from the Commission to the European Parliament, the Council, the Economic and Social Committee and the Committee of the Regions. Brussels, Belgium: 2002. https://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2002/0027/COM_COM(2002)0027_EN.pdf.

Organisation for Economic Co-operation and Development - OECD. The Bioeconomy to 2030: Designing a policy agenda. Paris, France: 2009. https://www.oecd-ilibrary.org/economics/the-bioeconomy-to-2030_9789264056886-en

Cooper M. Life as Surplus: Biotechnology and capitalism in the neoliberal era. 1st ed. Washington, USA: University of Washington Press; 2008.

Gottweis H, Salter B, Waldby C. The Global Politics of Human Embryonic Stem Cell Science. London: Palgrave Macmillan UK; 2009. https://doi.org/10.1057/9780230594364 DOI: https://doi.org/10.1057/9780230594364

Rosemann A, Bortz G, Vasen F, Sleeboom-Faulkner M. Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations. Regenerative Med 2016; 11:647–57. https://doi.org/10.2217/rme-2016-0072 DOI: https://doi.org/10.2217/rme-2016-0072

Bharadwaj A. Stem Cell Intersections: Perspectives and Experiences. Global Perspectives on Stem Cell Technologies, Cham: Springer International Publishing; 2018, p. 1–24. https://doi.org/10.1007/978-3-319-63787-7_1 DOI: https://doi.org/10.1007/978-3-319-63787-7_1

Waldby C, Mitchell R. Tissue Economies. Duke University Press; 2006. https://doi.org/10.1215/9780822388043 DOI: https://doi.org/10.2307/j.ctv11smkvp

Abbott A. Stem-cell ruling riles researchers. Nature 2013;495:418–9. https://doi.org/10.1038/495418a DOI: https://doi.org/10.1038/495418a

Franklin S. The IVF-stem cell interface. International Journal of Surgery 2006;4:86–90. https://doi.org/10.1016/j.ijsu.2006.02.008 DOI: https://doi.org/10.1016/j.ijsu.2006.02.008

Cohen CB, Cohen PJ. International Stem Cell Tourism and the Need for Effective Regulation: Part I: Stem Cell Tourism in Russia and India: Clinical Research, Innovative Treatment, or Unproven Hype? Kennedy Inst Ethics J 2010; 20:27–49. https://doi.org/10.1353/ken.0.0305 DOI: https://doi.org/10.1353/ken.0.0305

Murray S. Somatechnics. Routledge; 2016. https://doi.org/10.4324/9781315609867 DOI: https://doi.org/10.4324/9781315609867

Landecker H. Catherine Waldby and Robert Mitchell. Tissue Economies: Blood, Organs and Cell Lines in Late Capitalism. Durham, North Carolina, Duke University Press, 2006. viii, 231 pp. $74.95 (cloth), $21.95 (paper). J Hist Med Allied Sci 2007;62:270–2. https://doi.org/10.1093/jhmas/jrl059 DOI: https://doi.org/10.1093/jhmas/jrl059

Broxmeyer HE, Parker GC. Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies. Stem Cells Dev 2020; 29:625–6. https://doi.org/10.1089/scd.2020.0064 DOI: https://doi.org/10.1089/scd.2020.0064

Cuende N, Álvarez-Márquez AJ, Díaz-Aunión C, Castro P, Huet J, Pérez-Villares JM. Promoting the ethical use of safe and effective cell-based products: the Andalusian plan on regenerative medicine. Cytotherapy 2020; 22:712–7. https://doi.org/10.1016/j.jcyt.2020.07.007 DOI: https://doi.org/10.1016/j.jcyt.2020.07.007

Farias Vera L. The (mis)shaping of health. Problematizing neoliberal discourses of individualism and responsibility. In: Hosseini H, Goodman J, editors. The Routledge Handbook of Transformative Global Studies. 1st ed., New York, USA: Routledge; 2020, p. 268–81 DOI: https://doi.org/10.4324/9780429470325-16